Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT07898124Phase 1Recruiting
TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
HNSCCNeoplasm Recurrence, LocalRecurrent Head and Neck Squamous Cell Carcinoma+2 more
Studydirector

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Christopher Pack, PhD

Metaclipse Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalRecurrent Head and Neck Squamous Cell Carcinoma+1 more

Worked with same sponsors:

Metaclipse Therapeutics Corporation
Collaborated on 1 trial
Similarity Score44%

Kristen Jacobsen, PhD

Metaclipse Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalRecurrent Head and Neck Squamous Cell Carcinoma+1 more

Worked with same sponsors:

Metaclipse Therapeutics Corporation
Collaborated on 1 trial
Similarity Score44%

Michael Coleman, PhD

Metaclipse Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalRecurrent Head and Neck Squamous Cell Carcinoma+1 more

Worked with same sponsors:

Metaclipse Therapeutics Corporation
Collaborated on 1 trial
Similarity Score44%

Mercedes Porosnicu, MD

Wake Forest University Health Sciences

Related
6 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and Neck
Similarity Score15%

Douglas Adkins, M.D.

Washington University School of Medicine

Related
11 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckRecurrent Head and Neck Squamous Cell Carcinoma
Similarity Score15%

Douglas R Adkins, M.D.

Washington University School of Medicine

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckRecurrent Head and Neck Squamous Cell Carcinoma
Similarity Score15%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Neoplasm Recurrence, Local
Similarity Score8%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score8%

Zhen Jun Wang, M.D.

Beijing Chao Yang Hospital

Related
3 trials

Shared therapeutic areas:

Neoplasm Recurrence, Local
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07898124Phase 1StudyDirector

TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma

HNSCCNeoplasm Recurrence, LocalRecurrent Head and Neck Squamous Cell Carcinoma+2 more
Recruiting

All 1 trials loaded